Carol Ann Wiggins, MD | |
1800 Peachtree St. Nw, Suite 720, Atlanta, GA 30309-2511 | |
(404) 351-7520 | |
(404) 355-2048 |
Full Name | Carol Ann Wiggins |
---|---|
Gender | Female |
Speciality | Allergy/immunology |
Experience | 38 Years |
Location | 1800 Peachtree St. Nw, Atlanta, Georgia |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952339756 | NPI | - | NPPES |
000391454C | Medicaid | GA | |
0481392 | Other | AETNA | |
1472 | Other | COVENTRY | |
238523 | Other | BCBS | |
8792 | Other | KAISER | |
1591744008 | Other | CIGNA | |
030001445 | Other | GA | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207KA0200X | Allergy & Immunology - Allergy | 027134 (Georgia) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Piedmont Hospital | Atlanta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Peachtree Allergy And Asthma Clinic Pc | 2264458132 | 5 |
News Archive
Los Angeles Times: Three pharmaceutical firms — Roxane, Abbott Laboratories and B. Braun Medical — "agreed to pay more than $421 million to settle claims of defrauding Medicare and Medicaid — the latest in a string of large healthcare fraud settlements announced by the Justice Department. The drug companies charged one set of prices to doctors and pharmacies but reported another set of inflated figures that were used as benchmarks by government insurers reimbursing healthcare providers, authorities said" (Zajac, 12/8).
The National Institutes of Health has selected Axel Nimmerjahn for a highly competitive EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) grant. Dr. Nimmerjahn is an Assistant Professor in the Waitt Advanced Biophotonics Center and holds the Richard Allan Barry Developmental Chair.
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia.
The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?
The University of Western Ontario is one of nine universities which will share 2.9 million dollars in research grants announced by PrioNet Canada to study Prion diseases and neurodegenerative disorders including Alzheimer's.
› Verified 5 days ago
Entity Name | Peachtree Allergy And Asthma Clinic Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1811035652 PECOS PAC ID: 2264458132 Enrollment ID: O20051020000060 |
News Archive
Los Angeles Times: Three pharmaceutical firms — Roxane, Abbott Laboratories and B. Braun Medical — "agreed to pay more than $421 million to settle claims of defrauding Medicare and Medicaid — the latest in a string of large healthcare fraud settlements announced by the Justice Department. The drug companies charged one set of prices to doctors and pharmacies but reported another set of inflated figures that were used as benchmarks by government insurers reimbursing healthcare providers, authorities said" (Zajac, 12/8).
The National Institutes of Health has selected Axel Nimmerjahn for a highly competitive EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) grant. Dr. Nimmerjahn is an Assistant Professor in the Waitt Advanced Biophotonics Center and holds the Richard Allan Barry Developmental Chair.
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia.
The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?
The University of Western Ontario is one of nine universities which will share 2.9 million dollars in research grants announced by PrioNet Canada to study Prion diseases and neurodegenerative disorders including Alzheimer's.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Carol Ann Wiggins, MD 1800 Peachtree St. Nw, Suite 720, Atlanta, GA 30309-2511 Ph: (404) 351-7520 | Carol Ann Wiggins, MD 1800 Peachtree St. Nw, Suite 720, Atlanta, GA 30309-2511 Ph: (404) 351-7520 |
News Archive
Los Angeles Times: Three pharmaceutical firms — Roxane, Abbott Laboratories and B. Braun Medical — "agreed to pay more than $421 million to settle claims of defrauding Medicare and Medicaid — the latest in a string of large healthcare fraud settlements announced by the Justice Department. The drug companies charged one set of prices to doctors and pharmacies but reported another set of inflated figures that were used as benchmarks by government insurers reimbursing healthcare providers, authorities said" (Zajac, 12/8).
The National Institutes of Health has selected Axel Nimmerjahn for a highly competitive EUREKA (Exceptional Unconventional Research Enabling Knowledge Acceleration) grant. Dr. Nimmerjahn is an Assistant Professor in the Waitt Advanced Biophotonics Center and holds the Richard Allan Barry Developmental Chair.
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia.
The treatment of illness has traditionally been based on the law of averages – what works best for the largest number of patients. As a result, billions of dollars are spent every year on treatments that could be ineffective or even harmful for some patients. What if doctors could tell with a simple test which course of treatment would be best for a particular patient?
The University of Western Ontario is one of nine universities which will share 2.9 million dollars in research grants announced by PrioNet Canada to study Prion diseases and neurodegenerative disorders including Alzheimer's.
› Verified 5 days ago
Dennis L Spangler, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1150 Hammond Dr Ne, Building E Suite 350, Atlanta, GA 30328 Phone: 404-252-4207 Fax: 404-303-2758 | |
Marissa Shams, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2015 Uppergate Dr Ne, Atlanta, GA 30322 Phone: 404-778-2400 | |
Umbreen Saheed Lodi, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 2740 Bert Adams Rd. Nw, Suite 150, Atlanta, GA 30339 Phone: 404-351-7520 Fax: 404-355-2048 | |
Amy Hara Hirsh, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 1800 Peachtree St. Nw, Suite 720, Atlanta, GA 30309 Phone: 404-351-7520 Fax: 404-355-2048 | |
Jennifer Wenjing Xu, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 550 Peachtree St Ne, Atlanta, GA 30308 Phone: 510-579-8586 | |
Dr. Alan Redding, Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3193 Howell Mill Rd Nw, Suite 102, Atlanta, GA 30327 Phone: 404-355-0078 Fax: 404-355-0079 | |
Chih-yin Yeh, M.D Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 5673 Peachtree Dunwoody Rd # 445, Atlanta, GA 30342 Phone: 404-756-1393 |